Protocol for Detection of IL-4 by B-Cell Proliferation Assay
GUIDELINE
The stimulation of B lymphocytes by suboptimal doses of anti-IgM antibodies is weak. When interleukin 4 (IL-4) is added, B lymphocytes show a significant increase in DNA synthesis in response to stimulation with sub-adapted doses of anti-IgM antibody, and the amount of 3H-TdR doping correlates with the amount of IL-4. In this experiment, IL-4 has been detected by stimulating B cell proliferation with a sub-adapted dose of IsM antibody.
METHODS
- BALB/c or C57BL/6 mice are taken and splenic lymphocytes are isolated by conventional methods. Wash with Hanks' solution twice; then adjust the cell concentration to 1×107-2×107/mL with 10% NBS-IMDM culture medium.
- Place the above suspension of splenocytes in a 24-well culture plate, 1-1.5 mL per well, and incubate in a 37°C, 5% CO2 incubator for 1 h; transfer the cell suspension to another culture well, and continue to incubate for 1 h, and then collect the non-adherent splenocytes.
- Adjust the cell concentration to 5×107/mL, add anti-mouse T-cell serum or anti-Thy-1, 2McAb at 1:40 (V/V). Set at 4°C for 30 min, then add fresh guinea pig serum at 1:15 (V/V), mix well, and incubate for 1 h; centrifuge and discard the supernatant, and suspend the cells in a serum-free culture medium. At this time, T cells are dead and broken, through the lymphocyte layering solution, low-speed centrifugation to be removed.
- Centrifuge with lymphocyte layering solution at 500-800 r/min for 6-8 min, and purify the above cell suspension again. Wash 1-2 times with Hank's solution and adjust the cell concentration to 1×106-2×106/mL.
- Add the above B-cell suspension into a 96-well culture plate, add the IL-4 supernatant to be tested or different amounts of standards, the concentration of which is 0.5 U, 1 U, 2 U, 3 U, 4 U, 5 U, 6 U per milliliter, and set up 3 duplicate wells for each group.
- Add a sub-adaptive dose of anti-IgM antibody, generally the final concentration of 0.5% (V/V) for the sub-adaptive dose of anti-IgM, can also be measured before the experiment.
- The cells are routinely cultured for 48-72 h, and 3H-TdR is added 8-16 h before the end of the incubation period, and the cells are harvested to determine the cpm value. The cpm value of the standard is used to draw a standard curve, and the IL-4 activity is found from the standard curve.
Creative Bioarray Relevant Recommendations
- IL-4 is a pleiotropic cytokine produced by activated T cells, mast cells, and basophils. IL-4 stimulates the activation and differentiation of B cells as well as other hematopoietic and non-hematopoietic cells. Creative Bioarray provides high-quality Human Interleukin 4, Recombinant Human Interleukin 4, Recombinant Mouse Interleukin 4, Recombinant Human Interleukin 4 (for Cell Culture), Recombinant Human Interleukin 4 (E. coli), and others.
NOTES
- The purity of B cells has a direct impact on the results. The presence of T cells or dead T cells and their fragments in the B cell suspension can affect the results.
- When purifying B cell suspension, the operation time should be shortened as much as possible to reduce the unfavorable factors and ensure the cell viability, so that the experimental results are more stable and reproducible.
- The harvesting time of induced cell supernatant must be controlled at about 30 h. If the time is too long, the IL-4 content in the supernatant will be reduced.
RELATED PRODUCTS & SERVICES
For research use only. Not for any other purpose.
Resources
- FAQ
- Protocol
- Cell Culture Guide
- Technical Bulletins
-
Explore & Learn
-
Cell Biology
- Monocytes vs. Macrophages
- How to Detect and Remove Endotoxins in Biologics?
- Comparison of Different Methods to Measure Cell Viability
- Contamination of Cell Cultures & Treatment
- Generation and Applications of Neural Stem Cells
- Stem Cell Markers
- Quantification of Cytokines
- Comparison of the MSCs from Different Sources
- T Cell Activation and Expansion
- How to Isolate and Analyze Tumor-Infiltrating Leukocytes?
- Guidelines for Cell Banking to Ensure the Safety of Biologics
- Cell Cryopreservation Techniques and Practices
- What Are Myeloid Cell Markers?
- How to Start Your Culture: Thawing Frozen Cells
- Biomarkers and Signaling Pathways in Tumor Stem Cells
- Techniques for Cell Separation
- Circulating Tumor Cells as Cancer Biomarkers in the Clinic
- CFU Assay for Hematopoietic Cell
- What Is Cell Proliferation and How to Analyze It?
- Direct vs. Indirect Cell-Based ELISA
- Critical Quality Attributes and Assays for Induced Pluripotent Stem Cells
- Comparison of Several Techniques for the Detection of Apoptotic Cells
- STR Profiling—The ID Card of Cell Line
- How to Assess the Migratory and Invasive Capacity of Cells?
- Mesenchymal Stem Cells: A Comprehensive Exploration
- What Cell Lines Are Commonly Used in Biopharmaceutical Production?
- What are the Differences Between M1 and M2 Macrophages?
- Enrichment, Isolation and Characterization of Circulating Tumor Cells (CTCs)
- Cryopreservation of Cells Step by Step
- What are PBMCs?
- Neural Differentiation from Induced Pluripotent Stem Cells
- Isolation, Expansion, and Analysis of Natural Killer Cells
- Tumor Stem Cells: Identification, Isolation and Therapeutic Interventions
- Multi-Differentiation of Peripheral Blood Mononuclear Cells
- Tips For Cell Cryopreservation
- How to Decide Between 2D and 3D Cell Cultures?
- Organoid Differentiation from Induced Pluripotent Stem Cells
- Human Primary Cells: Definition, Assay, Applications
- What are Mesothelial Cells?
- How to Scale Up Single-Cell Clones?
- T Cell, NK Cell Differentiation from Induced Pluripotent Stem Cells
- Cell Culture Medium
- Major Problems Caused by the Use of Uncharacterized Cell Lines
- IL-12 Family Cytokines and Their Immune Functions
- Unveiling the Molecular Secrets of Adipogenesis in MSCs
- Troubleshooting Cell Culture Contamination: A Comprehensive Guide
- CHO Cell Line Development
- Strategies for Enrichment of Circulating Tumor Cells (CTCs)
- How to Eliminate Mycoplasma From Cell Cultures?
- How to Isolate PBMCs from Whole Blood?
- How to Handle Mycoplasma in Cell Culture?
- Spheroid vs. Organoid: Choosing the Right 3D Model for Your Research
- From Collection to Cure: How ACT Works in Cancer Immunotherapy
- Cell-Based High-Throughput Screening Techniques
- Overview of Cell Apoptosis Assays
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- Optimization Strategies of Cell-Based Assays
- Cell Immortalization Step by Step
- Adherent and Suspension Cell Culture
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- What Are CAR T Cells?
- Cell Viability, Proliferation and Cytotoxicity Assays
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- Immunogenicity Testing: ELISA and MSD Assays
- Cultivated Meat: What to Know?
- 3D-Cell Model in Cell-Based Assay
- Eosinophils vs. Basophils vs. Neutrophils
- Key Techniques in Primary, Immortalized and Stable Cell Line Development
- From Primary to Immortalized: Navigating Key Cell Lines in Biomedical Research
- Optimization Strategies of Cell-Based Assays
- 3D-Cell Model in Cell-Based Assay
- What Are the Pros and Cons of Adoptive Cell Therapy?
- How to Maximize Efficiency in Cell-Based High-Throughput Screening?
- Role of Cell-Based Assays in Drug Discovery and Development
- What are White Blood Cells?
- Types of Cell Therapy for Cancer
- Immunogenicity Testing: ELISA and MSD Assays
- Understanding Immunogenicity Assays: A Comprehensive Guide
- A Complete Guide to Immortalized Cancer Cell Lines in Cancer Research
- Exploring Cell Dynamics: Migration, Invasion, Adhesion, Angiogenesis, and EMT Assays
- Mastering Cell Culture and Cryopreservation: Key Strategies for Optimal Cell Viability and Stability
-
Histology
- Fluorescent Nuclear Staining Dyes
- Stains Used in Histology
- Troubleshooting in Fluorescent Staining
- Immunohistochemistry Controls
- Overview of the FFPE Cell Pellet Product Lines
- Tips for Choosing the Right Protease Inhibitor
- Comparison of Membrane Stains vs. Cell Surface Stains
- Microscope Platforms
- How to Apply NGS Technologies to FFPE Tissues?
- Overview of Common Tracking Labels for MSCs
- Multiple Animal Tissue Arrays
- Immunohistochemistry Troubleshooting
- Cell and Tissue Fixation
- Cell Lysates: Composition, Properties, and Preparation
- Mitochondrial Staining
- Guides for Live Cell Imaging Dyes
- Instructions for Tumour Tissue Collection, Storage and Dissociation
- How to Choose the Right Antibody for Immunohistochemistry (IHC)
- How to Begin with Multiplex Immunohistochemistry (mIHC)
- Common Immunohistochemistry Stains and Their Role in Cancer Diagnosis
- How Immunohistochemistry Makes the Invisible Brain Visible?
- Histological Staining Techniques: From Traditional Chemical Staining to Immunohistochemistry
- Modern Histological Techniques
- Multiplexing Immunohistochemistry
- What You Must Know About Neuroscience IHC?
- Comparing IHC, ICC, and IF: Which One Fits Your Research?
- From Specimen to Slide: Core Methods in Histological Practice
- Serum vs. Plasma
-
Exosome
- Emerging Technologies and Methodologies for Exosome Research
- How to characterize exosomes?
- Classification, Isolation Techniques and Characterization of Exosomes
- How Important are Lipids in Exosome Composition and Biogenesis?
- Common Techniques for Exosome Nucleic Acid Extraction
- How do PELN Deliver Drugs?
- Current Research Status of Milk Exosomes
- Collection of Exosome Samples and Precautions
- Exosome Size Measurement
- What are the Functions of Exosomal Proteins?
- How to Apply Exosomes in Clinical?
- Production of Exosomes: Human Cell Lines and Cultivation Modes
- Exosomes as Emerging Biomarker Tools for Diseases
- Techniques for Exosome Quantification
- How to Perform Targeted Modification of Exosomes?
- Exosome Transfection for Altering Biomolecular Delivery
- Summary of Approaches for Loading Cargo into Exosomes
- Exosome Antibodies
- Exosome Quality Control: How to Do It?
- Applications of MSC-EVs in Immune Regulation and Regeneration
- How to Enhancement Exosome Production?
- The Role of Exosomes in Cancer
- Unraveling Biogenesis and Composition of Exosomes
- What's the Potential of PELN in Disease Treatment?
- How to Label Exosomes?
- How to Efficiently Utilize MSC Exosomes for Disease Treatment?
-
ISH/FISH
- ISH probe labeling method
- Multiple Approaches to Karyotyping
- Comprehensive Comparison of IHC, CISH, and FISH Techniques
- RNAscope ISH Technology
- What are the Differences between FISH, aCGH, and NGS?
- CARD-FISH: Illuminating Microbial Diversity
- Overview of Common FISH Techniques
- Guidelines for the Design of FISH Probes
- In Situ Hybridization Probes
- Small RNA Detection by ISH Methods
- Comparative Genomic Hybridization and Its Applications
- Overview of Oligo-FISH Technology
- Differences Between DNA and RNA Probes
- How to Use FISH in Hematologic Neoplasms?
- What Is the Use of FISH in Solid Tumors?
- FISH Tips and Troubleshooting
- Multiple Options for Proving Monoclonality
- FISH Techniques for Biofilm Detection
- Whole Chromosome Painting Probes for FISH
- Telomere Length Measurement Methods
- What Types of Multicolor FISH Probe Sets Are Available?
- Different Types of FISH Probes for Oncology Research
- Reagents Used in FISH Experiments
- What are Single, Dual, and Multiplex ISH?
- Mapping of Transgenes by FISH
- ImmunoFISH: Integrates FISH and IL for Dual Detection
- 9 ISH Tips You Can't Ignore
-
Toxicokinetics & Pharmacokinetics
- How to Improve Drug Plasma Stability?
- How Is the Cytotoxicity of Drugs Determined?
- How to Improve the Pharmacokinetic Properties of Peptides?
- Toxicokinetics vs. Pharmacokinetics
- Key Considerations in Toxicokinetic
- Organoids in Drug Discovery: Revolutionizing Therapeutic Research
- What Are Metabolism-Mediated Drug-Drug Interactions?
- Key Factors Influencing Brain Distribution of Drugs
- The Rise of In Vitro Testing in Drug Development
- Predictive Modeling of Metabolic Drug Toxicity
- Effects of Cytochrome P450 Metabolism on Drug Interactions
- How to Improve Drug Distribution in the Brain
- Overview of In Vitro Permeability Assays
- Organ-on-a-Chip Systems for Drug Screening
- Experimental Methods for Identifying Drug-Drug Interactions
- Traditional vs. Novel Drug Delivery Methods
- What factors influence drug distribution?
- How to Design and Synthesize Antibody Drug Conjugates?
- What Is the Role of the Blood-Brain Barrier in Drug Delivery?
- Parameters of Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion
- Physical and Chemical Properties of Drugs and Calculations
- How to Conduct a Bioavailability Assessment?
- What are the Pharmacokinetic Properties of the Antisense Oligonucleotides?
- What Are Compartment Models in Pharmacokinetics?
- Pharmacokinetics Considerations for Antibody Drug Conjugates
- Unraveling the Role of hERG Channels in Drug Safety
- Comparison of MDCK-MDR1 and Caco-2 Cell-Based Permeability Assays
- Methods of Parallel Artificial Membrane Permeability Assays
- Pharmacokinetics of Therapeutic Peptides
- The 8 Costliest Mistakes in Preclinical CYP Phenotyping
- How Are Biomarkers Validated in Drug Development?
- Biomarkers vs. Functional Assays: Closing the Preclinical Gap
- When Should You Introduce ADME Tox Testing in Drug Development?
- How Can You Optimize Drug Toxicity Assessment?
- 6 Easy Steps to Get Your In Vitro ADME Done
- From Cells to Systems: Modern Approaches to Disease Modeling
- How to Choose the Right In Vitro ADME Assays for Small-Molecule Drugs
- What Are Biomarkers in Drug Discovery?
- How Genotoxicity Testing Guides Safer Drug Development
- Top 5 Pitfalls in In Vitro ADME Assays and How to Avoid Them
- 2D vs 3D Cell Culture Models: Which Is Best for Drug Toxicity Testing?
- Troubleshooting Common Issues in Drug Toxicity Testing
- What Is Genotoxicity in Pharmacology? Mechanisms and Sources
- Preclinical Workflow for Drug Toxicity Testing
- In Vitro ADME vs In Vivo ADME
- A Complete Guide to CYP Reaction Phenotyping in 2026
- How to Interpret CYP Phenotyping Data
- Reaction Phenotyping vs. Metabolic Stability
- The 8 Types of Drug Toxicity Every Researcher Must Know
- Why Cardiotoxicity Matters in R&D?
- What Are the Best Methods to Test Cardiotoxicity?
-
Disease Models
- Disease Models of Diabetes Mellitus
- Summary of Advantages and Limitations of Different Oncology Animal Models
- Animal Models of Neurodegenerative Diseases
- What Human Disease Models Are Available for Drug Development?
- Overview of Cardiovascular Disease Models in Drug Discovery
- Why Use PDX Models for Cancer Research?
- Preclinical Models of Acute Liver Failure
- Why Oncology Organoids Fail? How to Build Models That Work
- How to Select the Right Preclinical Model for Drug Development
-
Cell Biology
- Life Science Articles
- Download Center
- Trending Newsletter

